Most Recent
Construction PRO
Mardathoonera woman Raelene Cooper has taken Chevron and offshore petroleum regulator NOPSEMA to court over environmental approvals for a project for maintaining gas production from its Gorgon LNG project in Western Australia.
Discount grocery giant Aldi has partially succeeded on appeal of a finding that its Mamia Baby Puffs copied the look of rival Little Bellies baby snacks, but still faces possible additional damages for what a judge said was "flagrant" infringement.
A class action on behalf of public housing residents in the Northern Territory has lost its appeal of a judge's decision to split an upcoming trial.
A class action by public housing tenants in the Northern Territory claims a judge's decision to split the trial was based on a misunderstanding of fact and will lead to a "multiplicity of appeals".
The High Court has knocked back shipping company CSL Australia’s attempt to avoid paying millions of dollars in damages after its cement carrier crashed into two tugboats docked in a Tasmanian port.
Construction PRO
Addressing for the first time the question of compensation for 'future acts' under the Native Title Act, a judge has ordered Fortescue Metals Group to pay $150 million to compensate the Yinjibarndi people for losses stemming from the mining company's Solomon Hub iron ore project.
A judge has rejected as "approaching an abuse of process" a bid by internet provider Origin Net for more documents from power company Origin Energy ahead of next month's trial in their intellectual property stoush.
Aristocrat has fended off the Commissioner of Patents' challenge to a finding that its Lightning Link poker machine is capable of being patented, with the High Court declining to weigh in on the patent for a second time.
Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.